What does improvement mean?
Improvement is a change from where you started. It says nothing about where you end up. Two people can both improve and finish in different places, because they began in different places. That is the plain sense of my baseline point.
What did the trial behind this piece find?
The evidence checked for this piece is a randomised, evaluator-blinded trial of poly-L-lactic acid, one of the particles used in biostimulators, against an untreated group (Fabi and colleagues, 2024). It ran at US sites and enrolled adults with moderate or severe cheek wrinkles: 97 were treated and 52 were not. Treated people could have up to four sessions, a month apart.
The measurement that matters was a 3D camera analysis at month 9, run only on people who started with severe cheek wrinkles: 46 treated and 21 untreated. In the treated group, 42 of the 46 had a fourth session, a near-complete course. Their average change after up to four monthly sessions was measured in millimetres. Averaged across the whole midface, projection moved by less than a millimetre. The untreated group's averages were smaller on every measure.
These were bare averages from an exploratory analysis that was not a registered outcome, with no confidence intervals or p-values. Its authors advise caution. The manufacturer of the product tested funded the trial, and three of its four authors work for it.
Does the trial show that biostimulators improve severe laxity?
No. It did not measure laxity, and other things sit outside it:
Laxity. The scale grades cheek wrinkles, not laxity, and the highest severity grade was not enrolled.
Whether the gain depends on the baseline. Only the severe group had this analysis, so there is no moderate-baseline comparison. "The improvement depends on the baseline" stays my view, and none of the studies checked for this piece tests it.
Lift. The camera measured projection and volume, not how far the tissue was raised. A 2026 critical review examined how "lift" is measured in the filler literature. It found that reported millimetre effects are often similar in size to the imaging's accuracy (Harris and Michon). That does not show that nothing changed, only that the exact size is uncertain.
Other materials. It tested one, so it says nothing about the rest of the category.
Malaysian patients. It enrolled none.
What can "managing expectations" mean?
"Expectations need to be managed" is my phrase, and it is easier to say than to do. Three questions, asked of any doctor before starting, put it to work:
What will change, in words I can check?
When will the result be judged?
What happens if the change is smaller than I hoped?
On the second question: results in studies come from people who finished the whole course, judged months later. In this trial that meant months 7, 9 and 12. For the calendar, see how far ahead collagen-building courses need to start.
Ask for the answers in writing. In studies, written information improved recall in most trials but not all (Watson and McKinstry, 2009). Saying the plan back rests on less. In one small study, patients who recited the risks until they got them right recalled them better four hours later (White, 1995). Those trials were mostly about surgical consent, not injectable courses, so the support is limited.
Whether a biostimulator is the right tool for a face at all depends on which layer has softened, and only an examination can answer that. Before you begin, ask what size of change is realistic, and where significant excess skin is the main problem, a surgical opinion belongs in that conversation.
